BackFirst Tracks Biotherapeutics Ordinary Shares When-Issued Overview

First Tracks Biotherapeutics Ordinary Shares When-Issued Current Cash

Track First Tracks Biotherapeutics Ordinary Shares When-Issued's current cash ($170M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$168.02M

Peer trimmed avg / median

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Current Cash History

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued vs. peers: Current Cash Comparison

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

First Tracks Biotherapeutics Ordinary Shares When-Issued (TRAXV) FAQ

As of the most recent data (June 2026), TRAXV shows a current cash of $170M. Scroll down for historical charts and peer comparison views.

Tracking TRAXV's current cash over time shows whether First Tracks Biotherapeutics Ordinary Shares When-Issued is scaling, shrinking, or reshaping that part of the business. The current reading is $170M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has First Tracks Biotherapeutics Ordinary Shares When-Issued's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $170M) with ownership activity and broader fundamentals.

First Tracks Biotherapeutics Ordinary Shares When-Issued's current cash is $170M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.